LACTULOSE
Hepatic Encephalopathy
General Hospital of Shenyang Military RegionSmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 69/ 100
- Competitive Position
- 81/ 100
Competitive context
22 Active assets in the Hepatic Encephalopathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
L-Ornithine L-Aspartate Jinnah Postgraduate Medical Centre | Phase 4 | BBB |
Rifaximin General Hospital of Shenyang Military Region | Phase 4 | BBB |
NORMAL HUMAN SERUM ALBUMIN General Hospital of Shenyang Military Region | Phase 4 | BB |
L-Ornithine-L-Aspartate Qurratul Ain Jamil | Phase 4 | BB |
ORNITHINE Imperial College London | Phase 4 | BB |
View all 47 →
Same molecule, other indications
LACTULOSE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →